ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ABUS Arbutus Biopharma Corporation

3.12
-0.04 (-1.27%)
15 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Arbutus Biopharma Corporation ABUS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.04 -1.27% 3.12 14:00:00
Open Price Low Price High Price Close Price Previous Close
3.13 3.11 3.17 3.14 3.16
more quote information »

Recent News

Date Time Source Heading
07/6/202401:16EDGAR2Form 8-K - Current report
07/6/202401:15GLOBETreatment with Arbutus’ Imdusiran and VTP-300 Achieves..
05/6/202420:00EDGAR2Form 8-K - Current report
05/6/202416:30GLOBEArbutus’ Imdusiran with Short Course Interferon Achieves..
29/5/202421:30GLOBEArbutus to Participate in Jefferies Global Healthcare..
29/5/202406:25EDGAR2Form 8-K - Current report
25/5/202406:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/5/202406:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202420:00EDGAR2Form 8-K - Current report
22/5/202416:00GLOBEArbutus to Present Imdusiran Data at EASL Congress 2024
17/5/202423:03EDGAR2Form SC 13D/A - General statement of acquisition of..
17/5/202423:00BWWhitefort Capital Publishes Open Letter to Arbutus Biopharma..
09/5/202422:00EDGAR2Form SC 13D - General statement of acquisition of beneficial..
07/5/202421:30GLOBEArbutus to Participate in Two Upcoming Investor Conferences
02/5/202421:30GLOBEArbutus Reports First Quarter 2024 Financial Results and..
02/5/202421:25GLOBEArbutus Announces Retirement of Chief Scientific Officer,..
18/4/202421:30GLOBEArbutus to Report First Quarter 2024 Financial Results and..
04/4/202423:30GLOBEArbutus Biopharma Announces Claim Construction Ruling in its..
08/3/202423:30GLOBEArbutus to Participate in Two Upcoming Investor Conferences
06/3/202408:48EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202423:31EDGAR2Form 8-K - Current report
29/2/202423:30GLOBEArbutus Reports Fourth Quarter and Year End 2023 Financial..
15/2/202423:30GLOBEArbutus to Report Fourth Quarter and Year End 2023 Financial..
15/2/202408:38EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202402:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202411:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202411:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202411:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202411:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202423:31EDGAR2Form 8-K - Current report
08/1/202423:30GLOBEArbutus Announces 2024 Corporate Objectives and Provides..
05/1/202408:09EDGAR2Form 8-K - Current report
22/11/202300:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
10/11/202308:02EDGAR2Form 8-K - Current report
08/11/202323:30GLOBEArbutus to Present at Jefferies London Healthcare Conference
08/11/202308:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202323:31EDGAR2Form 8-K - Current report
07/11/202323:30GLOBEArbutus Reports Third Quarter 2023 Financial Results and..
07/11/202323:16EDGAR2Form 8-K - Current report
07/11/202323:15GLOBEArbutus Announces CEO, William Collier, to Retire December..
24/10/202322:30GLOBEArbutus to Report Third Quarter 2023 Financial Results and..
18/10/202322:30GLOBEArbutus to Present at H.C. Wainwright 4th Annual Hepatitis B..
11/10/202323:06EDGAR2Form 8-K - Current report
11/10/202323:05GLOBEArbutus Announces Multiple Abstracts Accepted for..
12/9/202307:07EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/9/202306:16EDGAR2Form 8-K - Current report
12/9/202306:15GLOBEArbutus Announces Pipeline Updates and Dosing of the First..
07/9/202321:30GLOBEArbutus to Participate in Two Upcoming Investor Conferences
04/8/202306:18EDGAR2Form S-8 - Securities to be offered to employees in employee..
04/8/202306:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]